Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2022-06-06 00:00:00 ET · period of report 2022-06-04 · accession 0001104659-22-068572 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-06-06 | 2022-06-04 | AMPH | Liawatidewi Yakob | EVP Corp Admin Center | F - Tax | $37.77 | -264 | 61.7K | -0.4% | -$9,971 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-04 | F | D | 264 | $37.77 | 61,735 | D | — | — | (F1) The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of restricted stock units, or RSUs. (F2) Includes 1,259 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2022. |